Cargando…
Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis
BACKGROUND: Microglia initiates and sustains the inflammatory reaction that drives the pathogenesis of pneumococcal meningitis. The expression of the G-protein cannabinoid receptor type 2 (CB2) in the brain is low, but is upregulated in glial cells during infection. Its activation down-regulates pro...
Autores principales: | Pan, Steven D., Grandgirard, Denis, Leib, Stephen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674855/ https://www.ncbi.nlm.nih.gov/pubmed/33251159 http://dx.doi.org/10.3389/fcimb.2020.588195 |
Ejemplares similares
-
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
por: Blaser, Cornelia, et al.
Publicado: (2010) -
Meningitis-associated pneumococcal serotype 8, ST 53, strain is hypervirulent in a rat model and has non-haemolytic pneumolysin which can be attenuated by liposomes
por: Müller, Annelies, et al.
Publicado: (2023) -
Pathogenic Differences of Type 1 Restriction-Modification Allele Variants in Experimental Listeria monocytogenes Meningitis
por: Zbinden, Florian R., et al.
Publicado: (2020) -
Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis
por: Wittwer, Matthias, et al.
Publicado: (2010) -
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2019)